imiloxan has been researched along with etomidate in 1 studies
| Studies (imiloxan) | Trials (imiloxan) | Recent Studies (post-2010) (imiloxan) | Studies (etomidate) | Trials (etomidate) | Recent Studies (post-2010) (etomidate) |
|---|---|---|---|---|---|
| 45 | 0 | 21 | 2,071 | 401 | 576 |
| Protein | Taxonomy | imiloxan (IC50) | etomidate (IC50) |
|---|---|---|---|
| Cytochrome P450 11B1, mitochondrial | Homo sapiens (human) | 0.0005 | |
| Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | 0.0009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for imiloxan and etomidate
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |